CureVac N.V. (CVAC) Establishes Subsidiary to Advance The RNA Printer(R
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
CureVac Establishes Fully-Owned Company Dedicated to Advancing The RNA Printer(R)
March 1, 2022 7:17 AM ESTThe RNA Printer(R) is CureVac's integrated and automated manufacturing solution for RNA vaccines and therapeuticsCureVac RNA Printer GmbH to provide dedicated infrastructure to accelerate development and broaden application range of The RNA Printer(R)Dr. Markus Bergmann appointed as General Manager for CureVac RNA Printer GmbH
TBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / March 1, 2022 / CureVac N.V. (NASDAQ: CVAC), a global biopharmaceutical company... More



